Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$2.97 -0.10 (-3.26%)
As of: Oct 21, 2026 · 10:32 AM EDT

Galmed Pharmaceuticals (EOCN) Non-cash Items (2024 - 2025)

Updated

Analysis

Galmed Pharmaceuticals (EOCN) Non-cash Items (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,132.10 Bn 1,100.69 Bn 19.71 Bn
2 Johnson & Johnson 615.67 Bn 534.20 Bn 17.26 Bn
3 AbbVie 504.61 Bn 477.72 Bn 12.70 Bn
4 Merck 368.03 Bn 322.41 Bn 12.21 Bn
5 Novartis Ag 298.24 Bn 262.23 Bn 11.24 Bn
6 Astrazeneca 261.77 Bn 235.46 Bn 12.86 Bn
7 Amgen 236.17 Bn 191.57 Bn 7.24 Bn
8 Gilead Sciences 190.62 Bn 164.81 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Galmed Pharmaceuticals 1.60 Mn -39.09 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 11,000.00
Dec 31, 2024 -30,000.00
API Access

Galmed Pharmaceuticals Non-cash Items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-cash-items&ticker=EOCN&period=max&api_key=YOUR_API_KEY